| Name |
Administration |
Indication |
| Rebetol® (ribavirin) |
oral |
Hepatitis |
| Rebif® (interferon beta-1a) |
SAI |
Multiple Sclerosis |
| Recombinate™ (antihemophilic
factor [recombinant]) |
non-SAI |
Hemophilia |
| ReFacto® (antihemophilic factor [recombinant]) |
non-SAI |
Hemophilia |
| Remicade® (infliximab) |
non-SAI |
Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis,
Psoriasis, Crohn's Disease, Ulcerative Colitis |
| Remodulin® (treprostinil sodium) |
non-SAI |
Pulmonary Arterial Hypertension |
| Repronex® (menotropins) |
non-SAI |
Infertility |
| Retisert® (fluocinolone acetonide) |
intraocular |
Non-infectious Uveitis |
| Revatio® (sildenafil citrate) |
oral |
Pulmonary Arterial Hypertension |
| Revlimid® (lenalidomide) |
oral |
Cancer |
| RhoGAM® (RHo[D] immune globulin [human]) |
non-SAI |
Rh isoimmunization |
| Rhophylac® (RHo[D] immune globulin intravenous
[human]) |
non-SAI |
Rh isoimmunization |
| RiaSTAPTM (fibrinogen) |
non-SAI |
Hemophilia |
| RibaPak® (ribavirin) |
oral |
Hepatitis |
| Ribasphere® (ribavirin) |
oral |
Hepatitis |
| Ribatab® (ribavirin) |
oral |
Hepatitis |
| Ribavirin (generic) |
oral |
Hepatitis |
| Rituxan® (rituximab) |
non-SAI |
Cancer |